Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ITD | Ann: ITL Update | 11/04/19 | 4 | 4.7K | |||
|
|||||||
ITD | Ann: Removal from Official List - Close of trade today | 15/02/19 | 0 | 719 | |||
|
|||||||
ITD | Ann: Daily share buy-back notice - Appendix 3E | 08/02/19 | 0 | 1.0K | |||
|
|||||||
ITD | Ann: ITL Share Cancellation | 08/02/19 | 0 | 644 | |||
|
|||||||
ITD | Ann: Suspension from Official Quotation - Close of trade today | 08/02/19 | 0 | 695 | |||
|
|||||||
ITD | Ann: Daily share buy-back notice - Appendix 3E | 08/02/19 | 0 | 693 | |||
|
|||||||
ITD | Ann: Daily share buy-back notice - Appendix 3E | 07/02/19 | 0 | 667 | |||
|
|||||||
ITD | Ann: Daily share buy-back notice - Appendix 3E | 06/02/19 | 0 | 549 | |||
|
See All Discussions